MarketLens
Sign Up

What Triggered uniQure's Sudden Stock Plunge

8 months ago
SHARE THIS ON:

What Triggered uniQure's Sudden Stock Plunge

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Uniqure Plummets 40% On Another Shocking Twist For Its Huntington's Drug

Uniqure shares fell 40% Tuesday after a four-year update on its experimental Huntington's disease gene therapy disappointed investors. The decline reflects renewed uncertainty over the program's durab...
Stock News•2 months ago

RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy

REGENXBIO (RGNX) fell 25% after the FDA placed a clinical hold on RGX-121 for MPS II, following asymptomatic spine MRI findings in five participants.
Stock News•4 months ago

QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway

UniQure's stock outlook hinges on AMT-130 FDA feedback, a Q3 2026 filing target, and cash runway into 2029.

Breaking News

View All →

Top Headlines

View More →
Stock News•18 minutes ago

California AG Rob Bonta serves Nvidia with subpoena in wake of ex-CEO Jensen Huang's Chinese spy, affairs scandals

Stock News•48 minutes ago

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages NVIDIA Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NVDA

Stock News•50 minutes ago

Alibaba defrauded shareholders by concealing ties to suspected spy in Nvidia scandal, lawsuit says

Stock News•1 hour ago

GOOGL; GOOG DEADLINE FOR INVESTORS: Alphabet Inc. Shareholders Encouraged to Contact Kirby McInerney LLP By December 1, 2026

Stock News•1 hour ago

California AG issues subpoena to Nvidia in probe of China chips